Niedermeyer Shannon E, Penfound Thomas A, Hohn Claudia, Li Yi, Homayouni Ramin, Zhao Jingnan, Dale James B
Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA Department of Veterans Affairs Medical Center, Memphis, Tennessee, USA.
Bioinformatics Program, University of Memphis, Memphis, Tennessee, USA.
Clin Vaccine Immunol. 2014 Oct;21(10):1421-5. doi: 10.1128/CVI.00448-14. Epub 2014 Jul 30.
Group A streptococci (GAS) (Streptococcus pyogenes) are common causes of infections in humans for which there is no licensed vaccine. Decades of work has focused on the role of the surface M protein in eliciting type-specific protective immunity. Recent studies have identified additional surface proteins of GAS that contain opsonic epitopes. In the present study, we describe a serotype M65 GAS originally isolated during an epidemiologic study in Bamako, Mali, which simultaneously expressed M, M-related protein (Mrp), and streptococcal protective antigen (Spa) on the bacterial surface. The emm, mrp, and spa genes were sequenced from PCR amplicons derived from the M65 chromosome. Rabbit antisera raised against synthetic peptides copying the N-terminal regions of M, Mrp, and Spa were highly specific for each peptide, reacted with the surface of M65 GAS, and promoted bactericidal activity against the organism. A mixture of antisera against all three peptides was most effective in the bactericidal assays. Immunofluorescence microscopy revealed that the M, Mrp, and Spa antisera bound to the bacterial surface in the presence of human plasma proteins and resulted in the deposition of complement. Five additional spa genes were identified in the Mrp-positive GAS serotypes, and their sequences were determined. Our results indicate that there are multiple antigens on the surface of GAS that evoke antibodies that promote bacterial killing. A more complete understanding of the relative contributions of M, Mrp, and Spa in eliciting protective immunity may aid in the development of GAS vaccines with enhanced coverage and efficacy.
A组链球菌(GAS,化脓性链球菌)是人类感染的常见病因,目前尚无获批的疫苗。数十年来的研究一直聚焦于表面M蛋白在引发型特异性保护性免疫中的作用。最近的研究发现了GAS的其他表面蛋白,这些蛋白含有调理素表位。在本研究中,我们描述了一株M65血清型GAS,最初是在马里巴马科的一项流行病学研究中分离得到的,该菌株在细菌表面同时表达M蛋白、M相关蛋白(Mrp)和链球菌保护性抗原(Spa)。从源自M65染色体的PCR扩增产物中对emm、mrp和spa基因进行了测序。用针对复制M、Mrp和Spa N端区域的合成肽制备的兔抗血清对每种肽具有高度特异性,能与M65 GAS的表面发生反应,并促进对该菌的杀菌活性。针对所有三种肽的抗血清混合物在杀菌试验中最有效。免疫荧光显微镜检查显示,在存在人血浆蛋白的情况下,M、Mrp和Spa抗血清与细菌表面结合,并导致补体沉积。在Mrp阳性的GAS血清型中鉴定出另外5个spa基因,并测定了它们的序列。我们的结果表明,GAS表面存在多种抗原,可诱发促进细菌杀伤的抗体。更全面地了解M、Mrp和Spa在引发保护性免疫中的相对作用,可能有助于开发覆盖范围更广、疗效更强的GAS疫苗。